Figure 1 | Scientific Reports

Figure 1

From: Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice

Figure 1

Animal model of regression. In the regular model, animals were either put on regular WTD as a control or WTD supplemented with rivaroxaban for 14 weeks. In our reversed model, all animals received WTD during the first 14 weeks. After 14 weeks, the group was divided in 2:1 group continued with WTD for the remainder of 6 weeks, and one group was switched to WTD supplemented with rivaroxaban.

Back to article page